Refine by MP, party, committee, province, or result type.

Results 1-15 of 46
Sorted by relevance | Sort by date: newest first / oldest first

Veterans Affairs committee  To date, I believe I've worked with three people who have been mefloquine exposed, two of whom had the prodromal reaction. One of them is a more recent one, so I was able to catch that and say what was going on there. The other one was the one who introduced me to the concept of

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

Veterans Affairs committee  Absolutely. In terms of the treatment, certainly, I think the psychological treatment of anxiety, depression and these kinds of issues that people are presenting with are going to be beneficial. We're going to help people cope more effectively, regardless of the source of the anx

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

Veterans Affairs committee  Thank you very much.

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

Veterans Affairs committee  It has a great deal of research behind it. Again, it's not a concept that is very well understood, but the idea is that the level of injustice somebody experiences subsequent to an injury predicts very strongly the duration of that disability. It predicts that, independent of the

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

Veterans Affairs committee  But we also have to recognize that putting up too many barriers actually makes the disability worse, which increases the costs to the system, never mind the personal costs to the individual who's suffering.

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

Veterans Affairs committee  I think when it comes to dealing with mefloquine, what we have to be able to do is to move quickly to a place where we can offer some kind of validation that we get it, we're hearing it, we're paying attention to it and we're listening to it. That's number one. Number two, it's

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

Veterans Affairs committee  I wouldn't, as I don't prescribe.

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

Veterans Affairs committee  Absolutely. In fact, this speaks again to the issue of what we should we be researching. Mefloquine exposure with a prodromal reaction and risk of suicide, that's retrospective research that could be done, and it would certainly be very important to understand the potential impac

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

Veterans Affairs committee  Yes. I think that's a very significant issue and it goes much beyond simply mefloquine. It's the issue of a soldier's right to consent to medical treatment, and it's a challenging one. We're sending people into an area where they may be exposed to certain diseases and we have the

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

Veterans Affairs committee  I'm afraid I simply can't give you an informed answer. I'm the wrong professional for that. I'm not sufficiently aware of other medications and their risks.

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

Veterans Affairs committee  It's an excellent question. I think it's a much more challenging one to identify people in the community who may have been exposed to the medication. Perhaps pharmaceutical records might lead to people who have received mefloquine in the past. Again, I think we might be up again

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

Veterans Affairs committee  The issue of sanctuary trauma are very important to me. I work with Badge of Life Canada, an organization devoted to helping police officers and corrections officers. I often speak on this topic at considerable length. It's almost hard for me to speak on it shortly, but I will do

April 29th, 2019Committee meeting

Dr. Jonathan Douglas

Veterans Affairs committee  I'm not aware. That would be outside of my purview, for sure.

April 29th, 2019Committee meeting

Dr. Jonathan Douglas